52w high/low | ₹7.28 / ₹1.82 |
P/E ratio | -42 |
Dividend | 0 |
ROE | 3 |
ROCE | 3.68 |
Face value | 5 |
Book value | ₹-1.54Cr |
Market capital | ₹7.16Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb. '90. It was subsequently converted into a public limited company with effect from 13 Jun. '92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123. 66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide.